United States Genomics Market Overview

Base Year: 2024

Historical Years: 2019-2024

Forecast Years: 2025-2033

Market Growth Rate: 19.4% (2025-2033)

The United States genomics market is a rapidly evolving sector at the forefront of precision medicine, driven by technological advancements, increased healthcare investment, and growing demand for personalized treatment solutions. According to the latest report by IMARC Group, United States genomics market size reached USD 13.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 65.5 Billion by 2033, exhibiting a growth rate (CAGR) of 19.4% during 2025-2033​. 

United States Genomics Industry Trends and Drivers:

Precision medicine and personalized healthcare are driving the U.S. genomics market. Next-generation sequencing (NGS) technologies are now cheaper and easier to access. This change helps in cancer genomics, rare disease diagnosis, and pharmacogenomics. More funding from public and private sectors, like the All of Us Research Program, speeds up genomic research and commercialization. Also, direct-to-consumer genetic testing services from companies like 23andMe and AncestryDNA are increasing consumer interest and expanding market reach. The growing use of CRISPR and gene-editing technologies in therapeutics is boosting the demand for genomic solutions.

More genetic disorders and cancer cases are pushing healthcare providers to use genomic testing. This helps with early detection and tailored treatments. Artificial intelligence and big data analytics improve how we interpret genomic data. This boosts accuracy and efficiency. Biotech firms, academic institutions, and pharmaceutical companies are working together. Their collaborations are driving innovation in gene therapies and diagnostics. Even with ethical and regulatory challenges, the market is expected to grow. Lower sequencing costs and broader insurance coverage for genetic tests support this growth. Liquid biopsy techniques are becoming popular for non-invasive cancer detection. This trend shows the powerful impact genomics can have on modern medicine.

Grab a sample PDF of this report: https://www.imarcgroup.com/united-states-genomics-market/requestsample

United States Genomics Industry Segmentation:

The report has segmented the market into the following categories:

Component Insights:

  • Products
    • Instruments and Software
    • Consumables and Reagents
  • Services
    • Core Genomics Services
    • NGS-Based Services
    • Biomarker Translation Services
    • Computational Services
    • Others

Technology Insights:

  • Sequencing
  • Microarray
  • Polymerase Chain Reaction
  • Nucleic Acid Extraction and Purification
  • Others

Application Insights:

  • Functional Genomics
  • Epigenomics
  • Biomarkers Discovery
  • Pathway Analysis
  • Others

End User Insights:

  • Research Centers
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others

Regional Insights:

  • Northeast 
  • Midwest 
  • South 
  • West

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Key highlights of the Report:

  • Market Performance (2019-2024)
  • Market Outlook (2025-2033)
  • COVID-19 Impact on the Market
  • Porter’s Five Forces Analysis
  • Strategic Recommendations
  • Historical, Current and Future Market Trends
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Structure of the Market
  • Value Chain Analysis
  • Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:  

IMARC Group 

134 N 4th St. Brooklyn, NY 11249, USA 

Tel No:(D) +91 120 433 0800 

United States: +1-631-791-1145